Coronavirus COVID-19 Updates: uc.edu/publichealth
Search By:
Head and neck Cancer (HNC) research strides with HEAL in the spotlight.
Cancer Center presents research at AACR 2025University of Cincinnati Cancer Center researchers will present abstracts at the American Association for Cancer Research Annual Meeting 2025 in Chicago.
Co-ops prepare UC grad for career in laboratory researchBeing in the lab full-time also gave Jansen the time to author and submit two abstracts to the American Association of Cancer Research conference, both of which were accepted. About a week prior to graduating on UC’s campus, Jansen was in Chicago presenting her work alongside cancer researchers from across the country — a rare accomplishment for an undergraduate student.
Immunotherapy inches forward in head and neck cancer trialsThe University of Cincinnati Cancer Center's Trisha Wise-Draper was featured in a Targeted Therapies in Oncology article discussing the current state and future of immunotherapy trials to treat head and neck cancer.
Shreya Shyamsunder’s review on the challenges and resistance mechanisms to EGFR targeted therapies in head and neck cancers and breast cancer (Oncotarget, June 2025. PMID: 40560045) was highlighted in a News Medical MSN article.
Vontz Center for Molecular StudiesTrisha Wise-Draper, MD, PhD3125 Eden Avenue, ML 0562, Room 1304Cincinnati, OH 45267-0562Office: 513-558-2826Email: wiseth@ucmail.uc.edu
Dalia ElGamal, MSc, PhD3125 Eden Avenue, ML0508, Room 1327Cincinnati, OH 45267-0562 Office: (513) 558 7932Email: elgamadm@ucmail.uc.edu
The Barrett Cancer CenterVinita Takiar, MD, PhD3151 Bellevue Avenue, ML 0757Cincinnati, OH 45219Office: 513-584-1450Email: takiarva@ucmail.uc.edu